TL13-110
TL13-110 is a negative control for TL13-112 (HY-123919) and a potent ALK inhibitor with an IC50 of 0.34 nM. TL13-110 does not degrade ALK in cells[1].
Product Specifications
CAS Number
[2229037-09-4]
UNSPSC
12352005
Target
Anaplastic lymphoma kinase (ALK)
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tl13-110.html
Solubility
10 mM in DMSO
Smiles
O=C(NCCOCCOCCN1CCC(C2=CC(OC(C)C)=C(NC3=NC=C(Cl)C(NC4=CC=CC=C4S(=O)(C(C)C)=O)=N3)C=C2C)CC1)CNC5=CC=CC(C(N6C7C(NCCC7)=O)=O)=C5C6=O
Molecular Formula
C49H62ClN9O9S
Molecular Weight
988.59
References & Citations
[1]Chelsea E Powell, et al. Chemically Induced Degradation of Anaplastic Lymphoma Kinase (ALK) . J Med Chem. 2018 May 10;61 (9) :4249-4255.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Human anti-SARS-CoV2 IgM (Coronavirus) BioAssayTM ELISA Kit (Research Use Only) discontinued
Rabbit anti-Arabidopsis thaliana (Mouse-ear cress) RBX1A Polyclonal Antibody
